Regeneron Pharmaceuticals, Inc.

Symbol: REGN

NASDAQ

982.82

USD

Market price today

  • 28.2894

    P/E Ratio

  • -2.1282

    PEG Ratio

  • 106.09B

    MRK Cap

  • 0.00%

    DIV Yield

Regeneron Pharmaceuticals, Inc. (REGN) Financial Statements

On the chart you can see the default numbers in dynamics for Regeneron Pharmaceuticals, Inc. (REGN). Companys revenue shows the average of 2585.271 M which is 0.382 % gowth. The average gross profit for the whole period is 2297.251 M which is 0.359 %. The average gross profit ratio is 0.827 %. The net income growth for the company last year performance is -0.089 % which equals -0.111 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Regeneron Pharmaceuticals, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.132. In the realm of current assets, REGN clocks in at 19479.2 in the reporting currency. A significant portion of these assets, precisely 10844.8, is held in cash and short-term investments. This segment shows a change of -0.243% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 5396.5, if any, in the reporting currency. This indicates a difference of -0.183% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 2702.9 in the reporting currency. This figure signifies a year_over_year change of 0.001%. Shareholder value, as depicted by the total shareholder equity, is valued at 25973.1 in the reporting currency. The year over year change in this aspect is 0.146%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 5667.3, with an inventory valuation of 2580.5, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 1038.6.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990

balance-sheet.row.cash-and-short-term-investments

38645.810844.814334.112532.7
6722.6
6471.1
4564.9
2896.1
1902.9
1677.4
1360.6
1083.9
587.5
526.9
626.9
341.3
474.8
766.5
459.3
298.5
296
293.8
264.3
385.1
117.6
66.2
19.8
28.9
34.5
32.7
23.6
12.5
16.4
26.2
21.8

balance-sheet.row.short-term-investments

279108114.84636.42809.1
1393.3
1596.5
1342.2
596.8
503.5
236.1
251.8
158.4
77.8
43.3
136.8
134.3
227
267.5
221.4
114
194.7
175.5
184.2
137.7
86.6
42.5
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

21491.75667.35328.76036.5
4114.7
2672.2
2243.2
1974.3
1611.6
1467.8
1017.4
891.8
693.1
103
93.1
65.6
35.2
18.3
7.5
36.5
43.1
15.5
4
3
13.8
0.6
5.7
6.6
4.3
2.7
1.7
1.7
1.1
1.4
0.2

balance-sheet.row.inventory

9020.32580.52401.91951.3
1916.6
1415.5
1151.2
726.1
399.4
238.6
128.9
70.4
28.6
13.6
-15.1
0
0
0
0
2.9
3.2
9
6.8
4
1.9
4.6
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

1728.3386.6933332.4
1164
959.3
243.3
225
130.5
163.5
120.7
140.8
176.2
810.5
15.1
18.6
11.5
13.1
3.2
3.4
1.6
1.9
1.8
2.2
0.8
1.6
67.4
64.1
46.2
13.8
26.7
77.6
67.2
79
0.4

balance-sheet.row.total-current-assets

71946.219479.222064.720520.5
12753.9
10558.8
7959.3
5596.6
3913.9
3383.8
2506.9
2252.2
1620.8
913.6
720.1
425.5
521.4
797.8
470
341.4
344
320.2
276.9
394.2
134.1
73
92.9
99.6
85
49.2
52
91.8
84.7
106.6
22.4

balance-sheet.row.property-plant-equipment-net

159564146.437633482.2
3221.6
2890.4
2575.8
2358.6
2083.4
1594.1
974.3
527
379.9
368
347.4
259.7
87.9
58.3
49.4
60.5
71.2
80.7
76.8
39.4
36.9
36.3
33
32.7
34.3
27.9
27.7
22.4
10.5
5.4
2.2

balance-sheet.row.goodwill

000-6844.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

3937.51038.6915.56.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.6
0.5

balance-sheet.row.goodwill-and-intangible-assets

3937.51038.6915.5-6838
-3135.6
-3256.8
-1755
-1486.5
-864.3
-632.2
-460.2
-621.8
-463.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.6
0.5

balance-sheet.row.long-term-investments

23568.85396.55406.46838
3135.6
3256.8
1755
1486.5
864.3
632.2
460.2
389.9
271.2
275.9
370.1
47.1
51.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

8955.62575.41723.7876.9
858.9
824.2
828.7
506.3
825.3
461.9
316.1
231.9
192
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

1596.8444.1-4658.8555.2
328.9
531.8
370.7
302.8
150.8
169.3
74.5
171.8
79.8
-233.8
-348.1
8.9
9.7
80.1
65.8
21.6
57.9
78.6
37.8
61.8
37.2
27.7
31
36.1
18.3
16.7
14.5
3.4
2.7
0.4
0.3

balance-sheet.row.total-non-current-assets

54014.7136017149.84914.3
4409.4
4246.4
3775.2
3167.7
3059.5
2225.4
1364.9
698.8
459.7
410
369.4
315.7
148.6
138.4
115.1
82.1
129.2
159.3
114.6
101.2
74.1
64
64
68.8
52.6
44.6
42.2
25.8
13.2
7.4
3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

125960.933080.229214.525434.8
17163.3
14805.2
11734.5
8764.3
6973.5
5609.1
3871.8
2951
2080.5
1323.6
1089.4
741.2
670
936.3
585.1
423.5
473.1
479.6
391.6
495.4
208.3
137
156.9
168.4
137.6
93.8
94.2
117.6
97.9
114
25.4

balance-sheet.row.account-payables

2290606.6589.2564
475.5
418.1
218.2
178.2
135
141
99.5
61.9
38.9
27.7
-48
18.6
6.3
8.1
21.5
23.3
18.9
18.9
30.3
14.8
9.4
6.6
5.6
4.7
4.4
6.3
5
10.3
2.5
1.6
0

balance-sheet.row.short-term-debt

00720719.7
1631.2
0
-90.8
468.8
127.3
452.6
350.2
0.9
1.4
1
0.7
0
-162.4
202.3
-21.5
-23.3
-18.9
13.8
0.1
0.4
0.6
1.4
1.1
1.8
3.6
3.5
3.1
1.6
1
0.4
0

balance-sheet.row.tax-payables

000.3326.3
19.5
49.4
20.8
0.2
235.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

10809.52702.92701.42699.7
2695.7
713.9
708.5
703.5
481.1
375.5
459.1
505.5
457.3
435.5
160
0
5.1
0
200
200
200
200
200
200.2
2.1
2.7
3.1
3.8
5.1
6
9.2
5.9
5.8
2.4
0

Deferred Revenue Non Current

453.7126.769.8515.3
635.5
1210.7
916.7
949.3
1062.4
818.2
250.3
231.2
259.2
248.6
340.6
137.9
162.4
0
123.5
69.1
56.4
68.8
5.5
6.9
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

50.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

9252.92357.91992.21725.3
122.4
781.1
772.1
0.3
486.7
13.6
96.4
152.4
27.5
73.3
53.7
30.4
29.9
28.8
21.5
23.3
18.9
0
0
0
3.7
5.3
2.7
4.2
4
3.1
9.8
1.2
1.1
1.3
0

balance-sheet.row.total-non-current-liabilities

14343.83683.72701.43215
3331.2
1924.6
1625.2
1652.8
1543.6
1193.7
709.4
736.7
716.5
435.5
500.6
250.9
167.5
192.3
323.5
269.1
256.4
269
205.5
207
12.4
14.2
16.3
18.8
18.7
13
9.2
6.1
6.1
4.5
11.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

2880720720719.7
717.2
713.9
708.5
703.5
481.1
364.7
312.3
185.2
160.8
160.5
160
0
0
0
0
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

27570.37107.16550.56666
6138
3715.5
2977.2
2620.2
2524.2
1954.3
1329.5
998.9
835.1
837.9
561.6
344.4
251.2
476
368.5
309.5
290.6
341.9
245.6
229
26.1
27.5
25.7
29.5
30.7
25.9
27.1
19.2
10.7
7.8
13.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0.40.10.10.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

102578.427260.323306.718968.3
10893
7379.8
5254.3
2946.7
1748.2
852.7
255.4
-92.7
-517.1
-1267.3
-1045.6
-941.1
-875.9
-793.2
-687.6
-585.3
-489.8
-531.5
-424.1
-299.7
-223.5
-200.3
-177.2
-168.6
-157
-124.6
-101.1
-70.4
-30.6
-11.4
-7

balance-sheet.row.accumulated-other-comprehensive-income-loss

-637-80.9-238.8-26.2
29.3
21.1
-12.3
0.6
-12.8
8.6
52.3
-1.2
-1.2
-1.9
-2.5
1
-0.1
0.2
-0.2
-0.8
-3.1
-4
-3.2
-1.6
-0.8
-0.5
-26.6
-23.6
-5.9
-5.9
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-3551.2-1206.4-404-173.4
102.9
3688.7
3515.2
3196.6
2713.8
2793.5
2234.6
2045.9
1763.5
1754.8
1575.8
1336.7
1294.8
1253.2
904.4
700
675.4
673.1
573.2
567.6
406.4
310.3
335
331.1
269.8
198.4
168.2
168.8
117.8
117.6
19.2

balance-sheet.row.total-stockholders-equity

98390.625973.12266418768.8
11025.3
11089.7
8757.3
6144.1
4449.2
3654.8
2542.3
1952.1
1245.4
485.7
527.8
396.8
418.9
460.3
216.6
114
182.5
137.6
146
266.4
182.1
109.5
131.2
138.9
106.9
67.9
67.1
98.4
87.2
106.2
12.2

balance-sheet.row.total-liabilities-and-stockholders-equity

125960.933080.229214.525434.8
17163.3
14805.2
11734.5
8764.3
6973.5
5609.1
3871.8
2951
2080.5
1323.6
1089.4
741.2
670
936.3
585.1
423.5
473.1
479.6
391.6
495.4
208.3
137
156.9
168.4
137.6
93.8
94.2
117.6
97.9
114
25.4

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

98390.625973.12266418768.8
11025.3
11089.7
8757.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

125960.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

36036.513511.310042.89647.1
4528.9
4853.3
3097.2
2083.3
1367.7
868.3
711.9
548.3
349
319.2
506.8
181.3
278
267.5
221.4
114
194.7
175.5
184.2
137.7
86.6
42.5
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

10809.52702.92701.42699.7
2695.7
713.9
708.5
703.5
481.1
375.5
459.1
505.5
457.3
435.5
160
0
5.1
202.3
200
200
200
213.8
200.2
200.6
2.7
4.1
4.2
5.6
8.7
9.5
12.3
7.5
6.8
2.8
0

balance-sheet.row.net-debt

73.7-27.1-404.5-185.9
502
-903.9
-759.2
-109.3
-54.1
-433.6
-189.7
-30.1
227.1
-48.1
47.5
-98.1
-242.7
-296.6
-37.9
15.5
98.8
95.5
120.1
-46.8
-28.3
-19.6
-15.6
-23.3
-25.8
-23.2
-11.3
-5
-9.6
-23.4
-21.8

Cash Flow Statement

The financial landscape of Regeneron Pharmaceuticals, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.171. The company recently extended its share capital by issuing 1145.5, marking a difference of 0.000 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -3185100000.000 in the reporting currency. This is a shift of -0.158 from the previous year. In the same period, the company recorded 421, 0, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

3953.63953.64338.48075.3
3513.2
2115.8
2444.4
1198.5
895.5
636.1
348.1
424.4
750.3
-221.8
-104.5
-67.8
-82.7
-105.6
-102.3
-95.4
41.7
-107.5
-124.4
-76.2
-23.2
-23.1
-8.6
-11.6
-32.4
-23.5
-30.7
-39.9
-19.1
-4.5

cash-flows.row.depreciation-and-amortization

421421341.4286.2
235.9
210.3
148.2
145.5
104.7
74.9
52.7
41.2
36.9
31.1
19.7
14.2
11.3
11.5
14.6
15.5
15.4
12.9
8.5
6.1
4.4
3.4
3
4.4
6.1
5.9
4.2
3.1
2
0.8

cash-flows.row.deferred-income-tax

-837.8-837.8-746.4-147.1
75.6
-130.6
-140
318.8
-360.1
-121.6
-66.6
63.6
-340.2
0
0
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

885885725601.7
432
464.3
427.4
507.3
559.9
459
307.2
198.4
94.2
56.1
39.9
31.3
32.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-94.1-94.1-243.3-1916.5
-1503.6
-200.5
-697
-926.5
228.2
229.8
20.2
-190.7
-672.8
-17.5
140.9
-49.5
-52.4
87.5
93
27.8
-58.7
84.3
3.6
11
-15.3
1.2
-7.4
-2.6
-8.5
-14.8
-3
3.1
1.5
-0.6

cash-flows.row.account-receivables

-338.8-338.8707.8-1927.4
-1356.1
-473.1
-268.9
-362.7
-143.8
-491.4
-62.4
-198.7
-590.1
-21.1
-27.5
-30.4
-16.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-271.7-271.7-696.5-494.3
-529.4
-335.5
-387.9
-314.2
-149.8
-111.8
-60.9
-48
-52.6
0
0
-4.6
0
0
3.6
1.3
6.9
-1
-1.7
-0.9
4
-4
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

487.4598.6-138.4866.1
118.9
444.5
210
-23.2
254
303.7
162.2
136.7
11
0
0
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

29-82.2-116.2-360.9
263
163.6
-250.2
-226.4
267.8
529.4
-18.7
-80.7
-41.1
3.7
168.5
-27.5
-35.5
87.5
89.4
26.5
-65.7
85.4
5.3
12
-19.3
5.2
-7.4
-2.6
-8.5
-14.8
0
0
0
0

cash-flows.row.other-non-cash-items

266.3266.3599.8181.7
-135
-29.3
12.1
-36.9
485.7
619.8
361.6
133.7
-861.8
10.4
0.3
-0.4
2.2
34
17.9
21.9
-15.2
4.1
1.8
1.8
6.1
4.7
2.8
3.7
14.5
14.2
9
3.6
-1.6
-2.5

cash-flows.row.net-cash-provided-by-operating-activities

4594000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-780.7-926.4-590.1-551.9
-614.6
-429.6
-383.1
-272.6
-511.9
-677.9
-333
-156.3
-49.3
-57.2
-99.7
-97.3
-34.9
-18.4
-2.8
-5
-6.2
-29.7
-34.4
-8.2
-6.5
-5.7
-3
-2.1
-8.6
-3.3
-6.9
-10.2
-2.1
-1

cash-flows.row.acquisitions-net

430.9-54.9-230.3551.9
614.6
429.6
1069.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-11646-11646-7487.9-7048.1
-3241
-3202.4
-1845.5
-1277.1
-809.4
-557.1
-564.2
-577.3
-470.4
-240.4
-612.2
-200
-581.1
-594.4
-456.9
-103
-276.3
-287.5
-240
-191.4
-104.9
-60.1
-88
-112.6
-74.6
-28.1
-22.5
-77.3
-71.6
-137.2

cash-flows.row.sales-maturities-of-investments

9442.29442.25550.52215.3
3785
1604.2
775.6
544.6
274.5
327.4
476.4
378.1
439.2
426.4
276.6
297.4
646.9
527.2
306.2
223.4
277.9
253.3
215.8
124.2
53.7
83.2
93.5
75.9
38.9
38.8
61.3
68.5
82.8
61.8

cash-flows.row.other-investing-activites

-631.50-1026.8-551.9
-614.6
-429.6
-1079.9
-732.6
-534.9
-229.7
-87.8
-199.1
-31.7
-0.3
1.1
0.1
-0.1
0
-1.6
0
0
0
0
0
0
0.1
-0.1
-0.1
0
0
0
-4.6
-0.9
-1.2

cash-flows.row.net-cash-used-for-investing-activites

-3185.1-3185.1-3784.6-5384.7
-70.6
-2027.8
-1463
-1005.2
-1046.9
-907.6
-420.8
-355.5
-81.1
128.5
-434.2
0.1
30.8
-85.7
-155.1
115.5
-4.6
-63.8
-58.5
-75.4
-57.7
17.5
2.4
-38.9
-44.3
7.4
31.9
-23.6
8.2
-77.6

cash-flows.row.debt-repayment

0000
-1500
0
0
-19.9
-40.6
-166.5
-221.7
-2
-2.2
-1.7
-1
0
-200.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

1145.51145.51519.51672.3
2575.2
211.8
114.5
240.2
126.7
206.4
126
57.4
63.5
18.5
196.8
8.6
7.9
319.4
185
4.1
1.5
94.7
2.1
158.5
94.4
1.4
0.5
43.4
70
23.2
0
51.1
0
91.6

cash-flows.row.common-stock-repurchased

-2935.6-2935.6-2528.5-2678.1
-6527.6
-463.9
-191.6
-301.7
-143.2
-160.5
-267.6
-195.1
-163.3
0
0
0
0
0
0
0
-0.9
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
-358.7
-500.2
-547.5
-294.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0000
3481.9
0
0
415.7
-143.2
405.3
448.6
216.9
4.3
367.4
47.5
22.8
0
0
0.4
0
3.8
13.5
-0.4
190.6
-1.5
-1.1
-1.9
-4
-3.7
-3.3
-0.2
-1.3
-0.8
-0.1

cash-flows.row.net-cash-used-provided-by-financing-activities

-1790.1-1790.1-1009-1005.8
-1970.5
-252.1
-77.1
-24.4
-700.4
-262.8
-209.3
77.1
-97.6
384.2
243.3
31.4
-192.9
319.4
185.4
4.1
4.4
108.2
1.7
349.1
92.9
0.3
-1.4
39.4
66.3
19.9
-0.2
49.8
-0.8
91.5

cash-flows.row.effect-of-forex-changes-on-cash

3764.9-0.400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-381.6-381.6221.3690.8
577
150.1
655
277.5
-273.9
160.4
113.1
305.3
-253.3
371
-94.5
-40.7
-251.1
261
53.4
89.3
-17.1
38.2
-167.3
216.4
7.3
3.9
-9.2
-5.6
1.7
9.1
11.2
-3.9
-9.8
7.1

cash-flows.row.cash-at-end-of-period

10776.52737.83119.42898.1
2207.3
1630.3
1480.2
812.7
535.2
809.1
648.7
535.6
230.3
483.6
112.6
207.1
247.8
498.9
237.9
184.5
101.2
118.3
80.1
247.4
31
23.7
19.7
28.9
34.4
32.7
23.7
12.5
16.4
26.3

cash-flows.row.cash-at-beginning-of-period

11158.13119.42898.12207.3
1630.3
1480.2
825.2
535.2
809.1
648.7
535.6
230.3
483.6
112.6
207.1
247.8
498.9
237.9
184.5
95.2
118.3
80.1
247.4
31
23.7
19.8
28.9
34.5
32.7
23.6
12.5
16.4
26.2
19.2

cash-flows.row.operating-cash-flow

459445945014.97081.3
2618.1
2430
2195.1
1307.1
1485.9
1330.8
752.4
588.6
-74.6
-141.7
96.3
-72.2
-89.1
27.4
23.1
-30.3
-16.9
-6.1
-110.5
-57.3
-27.9
-13.8
-10.2
-6.1
-20.3
-18.2
-20.5
-30.1
-17.2
-6.8

cash-flows.row.capital-expenditure

-780.7-926.4-590.1-551.9
-614.6
-429.6
-383.1
-272.6
-511.9
-677.9
-333
-156.3
-49.3
-57.2
-99.7
-97.3
-34.9
-18.4
-2.8
-5
-6.2
-29.7
-34.4
-8.2
-6.5
-5.7
-3
-2.1
-8.6
-3.3
-6.9
-10.2
-2.1
-1

cash-flows.row.free-cash-flow

3813.33667.64424.86529.4
2003.5
2000.4
1812
1034.5
974
652.8
419.4
432.3
-124
-198.9
-3.3
-169.5
-123.9
8.9
20.3
-35.3
-23.1
-35.8
-144.9
-65.5
-34.4
-19.5
-13.2
-8.2
-28.9
-21.5
-27.4
-40.3
-19.3
-7.8

Income Statement Row

Regeneron Pharmaceuticals, Inc.'s revenue saw a change of 0.078% compared with the previous period. The gross profit of REGN is reported to be 11301.4. The company's operating expenses are 7068.2, showing a change of 25.802% from the last year. The expenses for depreciation and amortization are 421, which is a -0.031% change from the last accounting period. Operating expenses are reported to be 7068.2, which shows a 25.802% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.146% year-over-year growth. The operating income is 4047.1, which shows a -0.146% change when compared to the previous year. The change in the net income is -0.089%. The net income for the last year was 3953.6.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990

income-statement-row.row.total-revenue

13117.213117.212172.916071.7
8497.1
7863.4
6710.8
5872.2
4860.4
4103.7
2819.6
2104.7
1378.5
445.8
459.1
379.3
238.5
125
63.4
66.2
174
57.5
22
22
59.3
34.5
38.2
33.1
24.1
27.4
23.2
10.6
11.5
7.3
5

income-statement-row.row.cost-of-revenue

1591.31815.81560.42437.5
1119.9
782.2
434.1
397.1
299.7
392.7
205
155.4
84.5
4.2
2.1
1.7
0.9
0
8.1
9.6
15.2
6.7
6.5
6.5
15.6
3.6
5
2.6
1.1
0
0
0
0
12.8
6.3

income-statement-row.row.gross-profit

11525.911301.410612.513634.2
7377.2
7081.2
6276.7
5475.2
4560.7
3711
2614.5
1949.4
1294
441.6
457
377.6
237.5
125
55.3
56.6
158.8
50.8
15.5
15.5
43.7
30.9
33.2
30.5
23
27.4
23.2
10.6
11.5
-5.5
-1.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

4439---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

68.1-20-89.9-45.6
-280.4
219.3
19.1
-1.1
-0.9
0
0
0
0
0
0
0
0
0
0
-248.8
0
0
0
0
4.4
3.4
3
4.4
6.1
5.9
4.2
3.1
2
0.8
0.3

income-statement-row.row.operating-expenses

7068.77068.25618.54687.4
3800.6
4871.4
3742.3
3395.6
3230
2459.1
1776.1
1189.4
836.3
646.8
554.5
451.7
327.4
239.5
163
-67.8
153.2
150.8
137.5
101.1
69
54.7
45.8
38
40.3
35
52.4
49.4
29.8
4.1
2

income-statement-row.row.cost-and-expenses

866088847178.97124.9
4920.5
5653.6
4176.4
3792.6
3529.7
2851.8
1981.1
1344.7
920.8
651
556.5
453.4
328.3
239.5
171.1
-58.2
168.4
157.5
143.9
107.7
84.6
58.3
50.8
40.6
41.4
35
52.4
49.4
29.8
16.9
8.3

income-statement-row.row.interest-income

495.9495.9160.145.8
18.5
30.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

37.47359.457.3
56.9
30.2
28.2
25.1
7.2
14.2
37.4
46.4
45.3
21.3
9.1
2.3
7.8
-20.9
-16.5
-41
-48.2
-4.5
-9.4
-12.2
4.6
-1
-4.4
3.4
14.3
14.7
0
0
0
-5.2
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

10.7-456.8119.9379
233.8
219.3
19.1
-1.1
-0.9
-12.6
-25.3
-0.2
2
3.5
2.1
4.5
17.2
20.9
16.5
41
48.2
4.5
9.4
12.2
-4.6
1
4.4
-3.4
-14.3
-14.7
0
0
0
5.2
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

68.1-20-89.9-45.6
-280.4
219.3
19.1
-1.1
-0.9
0
0
0
0
0
0
0
0
0
0
-248.8
0
0
0
0
4.4
3.4
3
4.4
6.1
5.9
4.2
3.1
2
0.8
0.3

income-statement-row.row.total-operating-expenses

10.7-456.8119.9379
233.8
219.3
19.1
-1.1
-0.9
-12.6
-25.3
-0.2
2
3.5
2.1
4.5
17.2
20.9
16.5
41
48.2
4.5
9.4
12.2
-4.6
1
4.4
-3.4
-14.3
-14.7
0
0
0
5.2
0

income-statement-row.row.interest-expense

37.47359.457.3
56.9
30.2
28.2
25.1
7.2
14.2
37.4
46.4
45.3
21.3
9.1
2.3
7.8
-20.9
-16.5
-41
-48.2
-4.5
-9.4
-12.2
4.6
-1
-4.4
3.4
14.3
14.7
0
0
0
-5.2
0

income-statement-row.row.depreciation-and-amortization

406.4421434.4436.3
290.7
210.3
148.2
145.5
104.7
74.9
52.7
41.2
36.9
31.1
19.7
14.2
11.3
11.5
14.6
15.5
15.4
12.9
8.5
6.1
4.4
3.4
3
4.4
6.1
5.9
4.2
3.1
2
0.8
0.3

income-statement-row.row.ebitda-caps

4611.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

4047.14047.14738.98946.8
3576.6
2209.8
2534.4
2079.6
1330.7
1251.9
838.4
760
457.7
-205.2
-97.5
-74.1
-89.8
-114.5
-107.7
124.4
5.6
-100
-122
-85.7
-25.3
-23.8
-12.6
-7.5
-17.3
-7.6
-29.2
-38.8
-18.3
-9.6
-3.3

income-statement-row.row.income-before-tax

4199.34199.34858.89325.8
3810.4
2429.1
2553.5
2078.5
1329.8
1225.1
775.7
713.4
414.4
-222.9
-104.5
-72
-80.4
-93.6
-91.1
124.4
53.9
-95.5
-112.5
-73.5
-29.9
-22.8
-8.2
-7.5
-17.3
-7.6
0
0
0
-4.4
0

income-statement-row.row.income-tax-expense

245.7245.7520.41250.5
297.2
313.3
109.1
880
434.3
589
427.7
289
-335.8
-1.1
-2.1
-4.1
2.4
-29.8
-21.9
178.8
-84.3
3
-7
-21.7
2.5
-1.7
-8.4
7.5
29.4
30.6
1.5
1.1
0.8
-10.3
0

income-statement-row.row.net-income

3953.63953.64338.48075.3
3513.2
2115.8
2444.4
1198.5
895.5
636.1
348.1
424.4
750.3
-221.8
-104.5
-67.8
-82.7
-105.6
-102.3
-95.4
41.7
-107.5
-124.4
-76.2
-23.2
-23.1
-8.6
-11.6
-32.4
-23.5
-30.7
-39.9
-19.1
-4.5
-3.3

Frequently Asked Question

What is Regeneron Pharmaceuticals, Inc. (REGN) total assets?

Regeneron Pharmaceuticals, Inc. (REGN) total assets is 33080200000.000.

What is enterprise annual revenue?

The annual revenue is 6797000000.000.

What is firm profit margin?

Firm profit margin is 0.879.

What is company free cash flow?

The free cash flow is 33.509.

What is enterprise net profit margin?

The net profit margin is 0.301.

What is firm total revenue?

The total revenue is 0.309.

What is Regeneron Pharmaceuticals, Inc. (REGN) net profit (net income)?

The net profit (net income) is 3953600000.000.

What is firm total debt?

The total debt is 2702900000.000.

What is operating expences number?

The operating expences are 7068200000.000.

What is company cash figure?

Enretprise cash is 2730000000.000.